{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:05:05Z","timestamp":1794344705499,"version":"4.9.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background\/Objectives<\/jats:title>\n                <jats:p>After Roux-en-Y gastric bypass (RYGB) a subset of patients never obtain excess BMI loss (EBMIL)\u2009&gt;\u200950% and are categorized as having primary weight loss (WL) failure. We hypothesized that postprandial concentrations of glucagon-like peptide 1 (GLP-1) and peptide YY (PYY) would be lower in patients with primary WL failure compared with patients with successfully maintained WL. Furthermore, that inhibition of gut hormone secretions would increase ad libitum food intake less in patients with primary WL failure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Subjects\/Methods<\/jats:title>\n                <jats:p>Twenty women with primary WL failure (LowEBMIL\u2009&lt;\u200950%) were individually matched to twenty women with successful WL (HighEBMIL\u2009&gt;\u200960%) on age, preoperative BMI and time from RYGB. On separate days performed in a random order, patient-blinded subcutaneous injections of octreotide or saline (placebo) were followed by a fixed breakfast and an ad libitum lunch with blood sampling for appetite regulating hormones and Visual-Analogue-Scale (VAS)-scoring of hunger\/satiety. Furthermore, participants underwent gene variant analysis for GLP-1, PYY and their receptors, indirect calorimetry, dual-energy X-ray absorptiometry (DXA)-scans, 4-days at-home food registration and 14-days step counting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>On placebo days, postprandial GLP-1, PYY and cholecystokinin (CCK) concentrations were similar between groups after breakfast. Fasting ghrelin was lower in LowEBMIL, but the postprandial suppression was similar. LowEBMIL had lower satiety VAS-scores and less suppression of hunger VAS-scores. Gene variants did not differ between groups. Octreotide diminished GLP-1, PYY, CCK and ghrelin concentrations in both groups. Octreotide did not affect ad libitum food intake in LowEBMIL (\u22121% [\u221213, 12], mean [95%CI]), while food intake increased in HighEBMIL (+23% [2,44]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Primary WL failure after RYGB was not characterized by impaired secretions of appetite regulating gut hormones. Interestingly, inhibition of gut hormone secretions with octreotide only increased food intake in patients with successful WL post-RYGB. Thus, an impaired central anorectic response to gut hormones may contribute to primary WL failure after RYGB.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41366-023-01372-8","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T06:02:09Z","timestamp":1693461729000},"page":"1143-1151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake"],"prefix":"10.1038","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1962-5302","authenticated-orcid":false,"given":"Kirstine Nyvold","family":"Bojsen-M\u00f8ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7345-4471","authenticated-orcid":false,"given":"Maria Saur","family":"Svane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer","family":"Martinussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2173-6469","authenticated-orcid":false,"given":"Carsten","family":"Dirksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Bruun","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Erik Beck","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Zinck","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6779-0252","authenticated-orcid":false,"given":"Signe S\u00f8rensen","family":"Torekov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viggo Bjerregaard","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Frederik","family":"Rehfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Bork-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5526-1070","authenticated-orcid":false,"given":"Niels","family":"Grarup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8748-3831","authenticated-orcid":false,"given":"Torben","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolette","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6853-3805","authenticated-orcid":false,"given":"Jens Juul","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten","family":"Madsbad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"1372_CR1","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s11695-014-1512-7","volume":"25","author":"A de Hollanda","year":"2015","unstructured":"de Hollanda A, Ruiz T, Jim\u00e9nez A, Flores L, Lacy A, Vidal J. Patterns of weight loss response following gastric bypass and sleeve gastrectomy. Obes Surg. 2015;25:1177\u201383.","journal-title":"Obes Surg."},{"key":"1372_CR2","doi-asserted-by":"publisher","first-page":"e046407","DOI":"10.1136\/bmjopen-2020-046407","volume":"11","author":"M Brissman","year":"2021","unstructured":"Brissman M, Beamish AJ, Olbers T, Marcus C. Prevalence of insufficient weight loss 5 years after Roux-en-Y gastric bypass: metabolic consequences and prediction estimates: a prospective registry study. BMJ Open. 2021;11:e046407.","journal-title":"BMJ Open"},{"key":"1372_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/oby.2008.507","volume":"17","author":"IJ Hatoum","year":"2009","unstructured":"Hatoum IJ, Stein HK, Merrifield BF, Kaplan LM. Capacity for physical activity predicts weight loss after Roux-en-Y gastric bypass. Obesity (Silver Spring). 2009;17:92\u201399.","journal-title":"Obesity (Silver Spring)"},{"key":"1372_CR4","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1007\/s11695-020-04877-7","volume":"30","author":"H Aliakbarian","year":"2020","unstructured":"Aliakbarian H, Bhutta HY, Heshmati K, Unes Kunju S, Sheu EG, Tavakkoli A. Pre-operative Predictors of Weight Loss and Weight Regain Following Roux-en-Y Gastric Bypass Surgery: a Prospective Human Study. Obes Surg. 2020;30:4852\u20139.","journal-title":"Obes Surg"},{"key":"1372_CR5","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1210\/jc.2012-3421","volume":"98","author":"ES Rinella","year":"2013","unstructured":"Rinella ES, Still C, Shao Y, Wood GC, Chu X, Salerno B, et al. Genome-wide association of single-nucleotide polymorphisms with weight loss outcomes after Roux-en-Y gastric bypass surgery. J Clin Endocrinol Metab. 2013;98:1131\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"1372_CR6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.soard.2015.01.011","volume":"11","author":"AP Courcoulas","year":"2015","unstructured":"Courcoulas AP, Christian NJ, O\u2019Rourke RW, Dakin G, Patchen Dellinger E, Flum DR, et al. Preoperative factors and 3-year weight change in the Longitudinal Assessment of Bariatric Surgery (LABS) consortium. Surg Obes Relat Dis. 2015;11:1109\u201318.","journal-title":"Surg Obes Relat Dis."},{"key":"1372_CR7","doi-asserted-by":"publisher","first-page":"E1630","DOI":"10.1210\/jc.2011-1130","volume":"96","author":"IJ Hatoum","year":"2011","unstructured":"Hatoum IJ, Greenawalt DM, Cotsapas C, Reitman ML, Daly MJ, Kaplan LM. Heritability of the weight loss response to gastric bypass surgery. J Clin Endocrinol Metab. 2011;96:E1630\u20133.","journal-title":"J Clin Endocrinol Metab"},{"key":"1372_CR8","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1007\/s11695-019-03878-5","volume":"29","author":"M Aasbrenn","year":"2019","unstructured":"Aasbrenn M, Schnurr TM, Have CT, Svendstrup M, Hansen DL, Worm D, et al. Genetic Determinants of Weight Loss After Bariatric Surgery. Obes Surg. 2019;29:2554\u201361.","journal-title":"Obes Surg"},{"key":"1372_CR9","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1038\/s41366-020-0576-9","volume":"44","author":"MS Nielsen","year":"2020","unstructured":"Nielsen MS, Christensen BJ, Schmidt JB, T\u00e6kker L, Holm L, Lunn S, et al. Predictors of weight loss after bariatric surgery\u2014a cross-disciplinary approach combining physiological, social, and psychological measures. Int J Obes. 2020;44:2291\u2013302.","journal-title":"Int J Obes"},{"key":"1372_CR10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/SLA.0b013e3180caa3e3","volume":"246","author":"CW le Roux","year":"2007","unstructured":"le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246:780\u20135.","journal-title":"Ann Surg"},{"key":"1372_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ijo.2015.162","volume":"40","author":"JB Schmidt","year":"2016","unstructured":"Schmidt JB, Pedersen SD, Gregersen NT, Vestergaard L, Nielsen MS, Ritz C, et al. Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial. Int J Obes (Lond). 2016;40:281\u201390.","journal-title":"Int J Obes (Lond)"},{"key":"1372_CR12","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s11695-012-0621-4","volume":"22","author":"SH Jacobsen","year":"2012","unstructured":"Jacobsen SH, Olesen SC, Dirksen C, J\u00f8rgensen NB, Bojsen-M\u00f8ller KN, Kielgast U, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg. 2012;22:1084\u201396.","journal-title":"Obes Surg."},{"key":"1372_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2020.01.003","volume":"76","author":"JF Rehfeld","year":"2020","unstructured":"Rehfeld JF. On measurement of cholecystokinin in plasma with reference to obesity studies. Nutr Res. 2020;76:1\u20138.","journal-title":"Nutr Res."},{"key":"1372_CR14","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1210\/jc.2015-3065","volume":"100","author":"A de Hollanda","year":"2015","unstructured":"de Hollanda A, Casals G, Delgado S, Jim\u00e9nez A, Viaplana J, Lacy AM, et al. Gastrointestinal Hormones and Weight Loss Maintenance Following Roux-en-Y Gastric Bypass. J. Clin Endocrinol Metab. 2015;100:4677\u201384.","journal-title":"J. Clin Endocrinol Metab"},{"key":"1372_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/ijo.2011.126","volume":"36","author":"WK Fenske","year":"2012","unstructured":"Fenske WK, Bueter M, Miras AD, Ghatei MA, Bloom SR, Le Roux CW. Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass. Int J Obes. 2012;36:379\u201384.","journal-title":"Int J Obes"},{"key":"1372_CR16","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1038\/ijo.2016.121","volume":"40","author":"MS Svane","year":"2016","unstructured":"Svane MS, J\u00f8rgensen NB, Bojsen-M\u00f8ller KN, Dirksen C, Nielsen S, Kristiansen VB, et al. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery. Int J Obes. (Lond). 2016;40:1699\u2013706.","journal-title":"Int J Obes. (Lond)."},{"key":"1372_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1210\/jc.2015-2665","volume":"101","author":"AP Goldstone","year":"2016","unstructured":"Goldstone AP, Miras AD, Scholtz S, Jackson S, Neff KJ, P\u00e9nicaud L, et al. Link between increased satiety gut hormones and reduced food reward after gastric bypass surgery for obesity. J Clin Endocrinol Metab. 2016;101:599\u2013609.","journal-title":"J Clin Endocrinol Metab"},{"key":"1372_CR18","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ijo.2013.15","volume":"37","author":"C Dirksen","year":"2013","unstructured":"Dirksen C, J\u00f8rgensen NB, Bojsen-M\u00f8ller KN, Kielgast U, Jacobsen SH, Clausen TR, et al. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. Int J Obes. (Lond). 2013;37:1452\u20139.","journal-title":"Int J Obes. (Lond)."},{"key":"1372_CR19","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.soard.2014.01.022","volume":"10","author":"A de Hollanda","year":"2014","unstructured":"de Hollanda A, Jim\u00e9nez A, Corcelles R, Lacy AM, Patrascioiu I, Vidal J. Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2014;10:814\u20139.","journal-title":"Surg Obes Relat Dis."},{"key":"1372_CR20","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1007\/s11695-019-04089-8","volume":"29","author":"E Sima","year":"2019","unstructured":"Sima E, Webb DL, Hellstr\u00f6m PM, Sundbom M. Non-responders after gastric bypass surgery for morbid obesity: peptide hormones and glucose homeostasis. Obes Surg. 2019;29:4008\u201317.","journal-title":"Obes Surg"},{"key":"1372_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/clinchem\/44.5.991","volume":"44","author":"JF Rehfeld","year":"1998","unstructured":"Rehfeld JF. Accurate measurement of cholecystokinin in plasma. Clin Chem. 1998;44:991\u20131001.","journal-title":"Clin Chem"},{"key":"1372_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1113\/jphysiol.1949.sp004363","volume":"109","author":"J Weir","year":"1949","unstructured":"Weir J. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol. 1949;109:1\u20139.","journal-title":"J Physiol"},{"key":"1372_CR23","first-page":"587","volume":"177","author":"AV Khera","year":"2019","unstructured":"Khera AV, Chaffin M, Wade KH, Zahid S, Brancale J, Xia R, et al. Polygenic prediction of weight and obesity trajectories from birth to adulthood. Cell Elsevier Inc. 2019;177:587\u201396.e9.","journal-title":"Cell Elsevier Inc"},{"key":"1372_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The ensembl variant effect predictor. Genome Biol. 2016;17:1\u201314.","journal-title":"Genome Biol."},{"key":"1372_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/sj.hdy.6800717","volume":"95","author":"J Li","year":"2005","unstructured":"Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb). 2005;95:221\u20137.","journal-title":"Heredity (Edinb)"},{"key":"1372_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/dom.14575","volume":"24","author":"V Vana","year":"2022","unstructured":"Vana V, L\u00e6rke MK, Rehfeld JF, Arnold M, Dmytriyeva O, Langhans W, et al. Vagal afferent cholecystokinin receptor activation is required for glucagon-like peptide-1\u2013induced satiation. Diabetes, Obes Metab. 2022;24:268\u201380.","journal-title":"Diabetes, Obes Metab."},{"key":"1372_CR27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","volume":"50","author":"M Tsch\u00f6p","year":"2001","unstructured":"Tsch\u00f6p M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50:707\u20139.","journal-title":"Diabetes"},{"key":"1372_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.orcp.2022.03.006","volume":"16","author":"S Nymo","year":"2022","unstructured":"Nymo S, Lundanes J, Aukan M, Sandvik J, Johnsen G, Gr\u00e6slie H, et al. Diet and physical activity are associated with suboptimal weight loss and weight regain 10\u201315 years after Roux-en-Y gastric bypass: A cross-sectional study. Obes Res Clin Pract. 2022;16:163\u20139.","journal-title":"Obes Res Clin Pract."},{"key":"1372_CR29","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1007\/s11695-016-2475-7","volume":"27","author":"T Amundsen","year":"2017","unstructured":"Amundsen T, Str\u00f8mmen M, Martins C. Suboptimal weight loss and weight regain after gastric bypass surgery\u2014postoperative status of energy intake, eating behavior, physical activity, and psychometrics. Obes Surg. 2017;27:1316\u201323.","journal-title":"Obes Surg"},{"key":"1372_CR30","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1007\/s11695-020-04387-6","volume":"30","author":"CC \u00d8hrstr\u00f8m","year":"2020","unstructured":"\u00d8hrstr\u00f8m CC, Worm D, Kielgast UL, Holst JJ, Hansen DL. Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass. Obes Surg. 2020;30:1038\u201345.","journal-title":"Obes Surg"},{"key":"1372_CR31","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1136\/gut.35.3_Suppl.S1","volume":"35","author":"AG Harris","year":"1994","unstructured":"Harris AG. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut. 1994;35:S1\u20134.","journal-title":"Gut"},{"key":"1372_CR32","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1210\/er.2018-00251","volume":"40","author":"NJ Wewer Albrechtsen","year":"2019","unstructured":"Wewer Albrechtsen NJ, Pedersen J, Galsgaard KD, Winther-S\u00f8rensen M, Suppli MP, Janah L, et al. The Liver\u2013\u03b1-Cell Axis and Type 2 Diabetes. Endocr Rev. 2019;40:1353\u201366.","journal-title":"Endocr Rev"},{"key":"1372_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11695-020-04856-y","volume":"31","author":"FF Horber","year":"2021","unstructured":"Horber FF, Steffen R. Reversal of Long-Term Weight Regain After Roux-en-Y Gastric Bypass Using Liraglutide or Surgical Revision. A Prospective Study. Obes. Surg. 2021;31:93\u2013100.","journal-title":"Obes. Surg."},{"key":"1372_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cob.12323","volume":"9","author":"S Wharton","year":"2019","unstructured":"Wharton S, Kuk JL, Luszczynski M, Kamran E, Christensen RAG. Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post\u2010bariatric surgery. Clin Obes. 2019;9:1\u20136.","journal-title":"Clin Obes."},{"key":"1372_CR35","first-page":"2","volume":"28","author":"WT Garvey","year":"2022","unstructured":"Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med Springer US. 2022;28:2\u20135.","journal-title":"Nat Med Springer US"},{"key":"1372_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;373:11\u201322.","journal-title":"N Engl J Med."},{"key":"1372_CR37","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/dom.13131","volume":"20","author":"T Tang","year":"2018","unstructured":"Tang T, Abbott S, le Roux CW, Wilson V, Singhal R, Bellary S, et al. Preoperative weight loss with glucagon-like peptide-1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis. Diabetes, Obes Metab. 2018;20:745\u20138.","journal-title":"Diabetes, Obes Metab."},{"key":"1372_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/obr.12013","volume":"14","author":"A Rudolph","year":"2013","unstructured":"Rudolph A, Hilbert A. Post-operative behavioural management in bariatric surgery: A systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2013;14:292\u2013302.","journal-title":"Obes Rev."},{"key":"1372_CR39","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/eat.23825","volume":"55","author":"L Paul","year":"2022","unstructured":"Paul L, van der Heiden C, van Hoeken D, Deen M, Vlijm A, Klaassen R, et al. Three- and five-year follow-up results of a randomized controlled trial on the effects of cognitive behavioral therapy before bariatric surgery. Int J Eat Disord. 2022;55:1824\u201337.","journal-title":"Int J Eat Disord"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-023-01372-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-023-01372-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-023-01372-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T14:05:14Z","timestamp":1698242714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-023-01372-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1372"],"URL":"https:\/\/doi.org\/10.1038\/s41366-023-01372-8","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"2 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CM has received support from Novo Nordisk A\/S for organizing\/attending meetings. JEBJ and SST have received research grants and lecture fees from Novo Nordisk A\/S. CD has served as advisor for Novo Nordisk A\/S and AstraZeneca and received lecture fees from Novo Nordisk A\/S. NBJ has served on advisory panels and in educational programs from Novo Nordisk A\/S, has received research support from Boehringer Ingelheim Denmark. In addition, NBJ reports having taken a position with Novo Nordisk A\/S as of March 2023. The remaining authors have no competing interests related to this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}